OncoSpear ApS: Financial statements 2024
CVR: 42093734
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
OncoSpear ApS (CVR 42093734) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -4,652,093 and a net result of DKK -6,461,139 compared with DKK -6,694,240 the year before. Equity in the 2024 report amounted to DKK 1,391,626. The solvency ratio was 42.8%. The company had 5 employees in the financial year.
- Gross Profit
- DKK -4,652,093
- Profit/Loss
- DKK -6,461,139
- Equity
- DKK 1,391,626
- Total Assets
- DKK 3,250,510
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -4.7M | -6.5M | 1.4M | 5 |
| 2023 | - | -5.4M | -6.7M | 7.9M | 5 |
| 2022 | - | -640K | -1.1M | 7.1M | 1 |
| 2021 | - | -26K | -26K | 24K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of October 30, 2024, Søren Kragh Moestrup has left the board of directors of OncoSpear ApS.
As of October 30, 2024, Holger Jon Møller has left the board of directors of OncoSpear ApS.
As of October 30, 2024, Anders Etzerodt has left the board of directors of OncoSpear ApS.
As of October 30, 2024, Toby Lawrence has left the board of directors of OncoSpear ApS.
As of October 30, 2024, Alexander Bharmal Demoulin has left the board of directors of OncoSpear ApS.
As of October 30, 2024, Debora Catharina Dumont has left the board of directors of OncoSpear ApS.
As of October 30, 2024, Geert Gilbert Tackaert is registered as director of OncoSpear ApS.
As of August 22, 2024, is registered as an owner of OncoSpear ApS with an ownership share of 100%.
OncoSpear ApS has published its annual report for 2023. Gross profit came to DKK -5,395,986, and the net result was DKK -6,694,240.
About OncoSpear ApS
OncoSpear ApS is a Danish company of the type Anpartsselskab based in Hinnerup, founded in 2021. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Geert Gilbert Tackaert and Niels Jonas Heilskov Graversen. The company is owned by SPICA THERAPEUTICS. The company has 8 employees (2026). In 2025, the company reported a gross profit of DKK 2,927,421 and a net result of DKK -821,765 compared with DKK -6,461,139 the year before. Equity in the 2025 report amounted to DKK 569,861.